Evaluation of the GlucoTrack, Non-Invasive Glucose Monitoring Device

NCT00433758 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 142

Last updated 2008-03-18

No results posted yet for this study

Summary

The purpose of this study is to demonstrate the performance of the GlucoTrack device (non invasive device) in measuring blood glucose levels

Conditions

Interventions

DEVICE

GlucoTrack

GT

Sponsors & Collaborators

  • Integrity Applications Ltd.

    lead INDUSTRY

Principal Investigators

  • Ilana Harman-Boehm, MD · Soroka University Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
10 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-12-31
Completion
2008-12-31

Countries

  • Israel

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00433758 on ClinicalTrials.gov